Trusted Resources: Education
Scientific literature and patient education texts
Early and Late Brain Resonance Findings of Two Siblings With Hunter Syndrome
source: Revista de Neurologia
year: 2021
authors: Silvestre-Avendaño JJ,Morales-Vásquez DE,Muñoz-Zuñiga JR
summary/abstract:Mucopolysaccharidosis type II (MPS II) is a lysosomal disease caused by deficiency of the enzyme iduronate-2-sulfatase (IDS), linked to the X chromosome, producing a wide spectrum of clinical manifestations.
organization: Universidad Nacional de Colombia, Bogotá DC, Colombia.DOI: 10.33588/rn.7301.2021203
read more
BookmarkRelated Content
-
Mount Sinai – Lysosomal Storage Disease ProgramThe Mount Sinai Hospital’s Lysosomal S...
-
Bone Biomarkers in MucopolysaccharidosesThe accumulation of glycosaminoglycans (...
-
Mucopolysaccharidosis Type I Disease Prevalence Among Patients With Idiopathic Short Stature in Saudi Arabia: Protoc...Since the underlying cause of idiopathic...
-
Corneal Cloudiness: A Presenting Feature of Mucopolysaccharidosis Type IA 10-y-old ‘short-statured’ male pre...
-
Understanding Mucopolysaccharidosis Type VII (MPS VII) or Sly SyndromeMPS VII, also called Sly syndrome, is a ...
-
Establishing a Core Outcome set for Mucopolysaccharidoses (MPS) in Children: Study Protocol for a Rapid Literature R...Mucopolysaccharidoses (MPS) are a group ...
-
Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the LiteratureMucopolysaccharidosis type III (MPS III,...
Powered by
